Tim Overkamp

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma

Bernhard Gillissen, Jana Wendt, Antje Richter et al. · The Journal of Cell Biology · 2010 · 68 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level

Vilma Graupner, E. A. Alexander, Tim Overkamp et al. · Cell Death and Differentiation · 2011 · 61 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode

Bernhard Gillissen, Antje Richter, Antje Richter et al. · Cell Death and Disease · 2013 · 46 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Strength of basalt fibers influenced by thermal and chemical treatments

Tim Overkamp, Boris Mahltig, Yordan Kyosev · Journal of Industrial Textiles · 2016 · 36 citations

Natural Sciences, Materials Engineering, Materials Science +13

p14ARF-induced Apoptosis in p53 Protein-deficient Cells Is Mediated by BH3-only Protein-independent Derepression of Bak Protein through Down-regulation of Mcl-1 and Bcl-xL Proteins

Annika Müer, Tim Overkamp, Antje Richter et al. · Journal of Biological Chemistry · 2012 · 27 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17